Compliance Certificate For The Period Ended 31.03.2018
Reg. 7(3) RTA Compliance Certificate for the period ended 31.03.201810-04-2018
10-04-2018
Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0330 Name of the Signatory :- Harshavardhan PanigrahiDesignation :- Company Secretary and Compliance Officer10-04-2018
Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mr. Digant Mahesh Parikh as Independent Director14-03-2018
Announcement under Regulation 30 (LODR)-Updates
Enclosed herewith kindly find Dividend Distribution Policy of the Company approved and adopted by the Board of Directors of the Company at its meeting held today i.e. Monday, 12th February, 2018.12-02-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release dated 12.02.201812-02-2018
Board Meeting-Outcome of Board Meeting
Sub: Unaudited Financial Results for the quarter ended 31st December, 2017 and Limited Review Reports thereon. Dear Sir, In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results for the quarter ended 31st December, 2017 (both Standalone and Consolidated) approved by the Board of Directors at its meeting held today i.e. 12th...12-02-2018
Closure of Trading Window
Dear Sir, This is to inform you that the Meeting of the Board of Directors of the Company will be held on Monday, 12th February, 2018 at Mumbai, to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the quarter ended 31st December, 2017. Please note that as per the Insider Trading Code of the Company, the Trading Window for dealing in Company's shares will remain closed for...02-02-2018
Shareholding for the Period Ended December 31, 2017
Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here19-01-2018
Statement Of Investor Complaints For The Quarter Ended December, 2017
Statement of Investor Complaints for the quarter ended December, 2017 under Regulation 13(3) of SEBI (LODR), 2015.10-01-2018